Requiring the State Board of Pharmacy to determine and prepare a list of the prescription drugs that may be considered specialty drugs by a pharmacy benefits manager; requiring the Board to publish its list of specialty drugs in the Maryland Register every 6 months; specifying the prescription drugs that a pharmacy benefits manager may designate as specialty drugs on a formulary; etc.